Aspetuck Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Buy
511
+17
+3% +$17.4K 0.36% 54
2026
Q1
$454K Buy
494
+2
+0.4% +$2.03K 0.31% 57
2025
Q4
$529K Sell
492
-5
-1% -$4.78K 0.36% 52
2025
Q3
$379K Sell
497
-10
-2% -$7.44K 0.26% 59
2025
Q2
$395K Buy
507
+150
+42% +$117K 0.3% 55
2025
Q1
$295K Buy
357
+65
+22% +$54.1K 0.25% 60
2024
Q4
$225K Buy
+292
New +$242K 0.18% 68

Other funds holding LLY

Aspetuck Financial Management's LLY Position: Q2 2026 in Review

Aspetuck Financial Management increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $17.4K and bringing the position to 511 shares worth $613K. The position accounts for 0.36% of the portfolio, ranked #54.

Aspetuck Financial Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspetuck Financial Management held 511 shares of Eli Lilly worth $613K as of Q2 2026.
  • Aspetuck Financial Management bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.36% of Aspetuck Financial Management's portfolio in Q2 2026, its #54 holding.
  • Aspetuck Financial Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspetuck Financial Management's 13F filing for Q2 2026, filed 11 Aug 2026.